AzTrials
AzTrials

CapnographyNCT05817864

Diagnostic Accuracy of Capnography in Nasogastric Tube Placement

An observational study of Capnography and Nasogastric Tube, run by Chinese University of Hong Kong at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A prospective observational diagnostic study will be conducted to assess the sensitivity and specificity of using capnography in detecting the correct placement of nasogastric tubes using the reference standards of radiography and measurement of aspirates for pH value. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Capnography, Nasogastric Tube, Diagnostic Accuracy
What is being tested?
Capnography
How many people
390 participants
Where
1 siteChina
Study dates
1 Jul 2023to Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: A convenience sampling method will be adopted in this study. The participants will be recruited from general medical and geriatric wards, ICUs, AEDs, and subacute/rehabilitation/infirmary wards in 21 acute or subacute/convalescent/extended care hospitals. Each participant will be included in the study once.

Who may be able to join

  • 18 years old or above;
  • Admitted to the general medical and geriatric wards, ICUs, or subacute/rehabilitation/infirmary wards in subacute/convalescent/extended care hospitals or visiting AEDs in acute hospitals;
  • Requiring the insertion of an nasogastric tube into the stomach for assessment, nutritional support and medication administration during the study period.

Who cannot join

  • Participants receiving life-saving intervention at the time of recruitment.

Trial locations and contacts

1 site in 1 country.

Janita Pak Chun Chau, PhD contact

+852 3943 6226

janitachau@cuhk.edu.hk

Suzanne Hoi Shan Lo, PhD contact

+852 3943 4485

suzannelo@cuhk.edu.hk

China1 site, 1 recruiting
  • The Chinese University of Hong Kong

    Hong Kong, Hong Kong SAR

    Janita Pak Chun Chau, PhD, +852 3943 6226, janitachau@cuhk.edu.hk

    Recruiting

Other trials in China

About this study

Official title: Diagnostic Accuracy of Using Capnography in Verification of Nasogastric Tube Placement in Hospital Settings

A prospective observational diagnostic study will be conducted to assess the sensitivity and specificity of using capnography in detecting the correct placement of nasogastric tubes using the reference standards of radiography and measurement of aspirates for pH value.

Read the detailed description

A prospective observational diagnostic study will be conducted. Patients ≥ 18-year-old and requiring the insertion of an nasogastric tube will be recruited using a convenience sampling method from general medical and geriatric wards, intensive care units (ICUs), accident and emergency departments (AEDs), and subacute/rehabilitation/infirmary wards in 21 acute or subacute/convalescent/extended care hospitals. End-tidal carbon dioxide (ETCO2) detection by sidestream capnography, which indicates airway intubation of an nasogastric tube when a capnogram waveform or an ETCO2 level > 10 mmHg, will serve as the index test. The reference standards will be the pH value of gastric content aspiration (pH ≤ 5.5 indicates gastric placement) and X-ray performed after the index test. Each participant will be included only once. Sensitivity, specificity, positive predictive value, and negative predictive value, and the area under the receiver operating characteristic curve of capnography will be calculated to assess the diagnostic performance of capnography. The variability in diagnostic accuracy in participants with different characteristics will be compared. The time spent and the cost of the index test and the reference test will be compared.

This study will provide evidence on the diagnostic accuracy of capnography in verifying nasogastric tube placement and inform the update of clinical practice guidelines and stakeholders' decisions regarding the adoption of ETCO2 detection as a routine method for verifying nasogastric tube placement.

Being tested
Capnography
Keywords
Capnography, Intubation, gastrointestinal, Diagnostic accuracy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CapnographyDiagnostic test

    Index test: Capnography, which monitors ETCO2, the percentage concentration, or partial pressure of CO2 at the end of exhalation, will serve as the index test. It will be performed by connecting the end of the nasogastric tube with the sensor of the bedside sidestream capnography device. Placement within the airway is defined as detecting a capnogram waveform or an ETCO2 level > 10 mmHg.

    Reference standard: This study will use radiography (chest/abdominal X-ray) as the reference standard for determining the correct placement of nasogastric tubes. Radiology will be performed as soon as possible and interpreted by a physician. A repeat radiography will be performed if necessary. We will also use pH-Fix-4.5-10 to determine the pH value, and its accuracy is +/- 0.2 pH with minimum increments of 0.5. A pH of 5.5 or below indicates gastric placement.

Study groups in NCT05817864
Study groupRoleWhat they receive
Observational groupAll participants included will be in one observational cohort.
Receives: Diagnostic Test: Capnography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensitivity of Capnography

    True Positive / (True Positive + False Negative) × 100%

    Measured: Through study completion, an average of 2 year

  2. Specificity of Capnography

    True Negative / (True Negative + False Positive) × 100%

    Measured: Through study completion, an average of 2 year

  3. Positive Predictive Value of Capnography

    True Positive / (True Positive + False Positive) × 100%

    Measured: Through study completion, an average of 2 year

  4. Negative Predictive Value of Capnography

    True Negative / (True Negative + False Negative) × 100%

    Measured: Through study completion, an average of 2 year

  5. Overall diagnostic performance of Capnography

    Measured by the area under the receiver operating characteristic curve (AUROC). The test accuracy level is considered high when the AUROC value is ≥ 0.9.

    Measured: Through study completion, an average of 2 year

Secondary outcomes (2)
  1. Difference in the time spent of index test and reference test

    Compare the time spent of index test (i.e., capnography) and reference test (i.e., radiography)

    Measured: Through study completion, an average of 2 year

  2. Difference in the cost of index test and reference test

    Compare the cost of index test (i.e., capnography) and reference test (i.e., radiography)

    Measured: Through study completion, an average of 2 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2023
  2. Study start1 Jul 2023
  3. Primary completionJun 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
390 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05817864
Sponsor's protocol ID
2022073
Status last verified
Sep 2024
First submitted
23 Mar 2023
Last updated
5 Sep 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The datasets generated during and/or analysed during the current study will be available from the principal investigator on reasonable request.

Publications

  • Chau JP, Thompson DR, Fernandez R, Griffiths R, Lo HS. Methods for determining the correct nasogastric tube placement after insertion: a meta-analysis. JBI Libr Syst Rev. 2009;7(16):679-760. doi: 10.11124/01938924-200907160-00001.

    PubMed 27820026
  • Chau JP, Lo SH, Thompson DR, Fernandez R, Griffiths R. Use of end-tidal carbon dioxide detection to determine correct placement of nasogastric tube: a meta-analysis. Int J Nurs Stud. 2011 Apr;48(4):513-21. doi: 10.1016/j.ijnurstu.2010.12.004. Epub 2011 Jan 7.

    PubMed 21215969
  • Chau JPC, Liu X, Choi KC, Lo SHS, Lam SKY, Chan KM, Zhao J, Thompson DR. Diagnostic accuracy of end-tidal carbon dioxide detection in determining correct placement of nasogastric tube: An updated systematic review with meta-analysis. Int J Nurs Stud. 2021 Nov;123:104071. doi: 10.1016/j.ijnurstu.2021.104071. Epub 2021 Aug 24.

    PubMed 34520886
  • Chau JPC, Tong DWK, Lo SHS, Sze SYM, Kwok MLM, Lai PCK, Lam HKC, Chung JYM, Liu X, Chien WT, Choi KC. Diagnostic accuracy of using capnography in verification of nasogastric tube placement among adult patients in hospital settings: Protocol of a diagnostic study. PLoS One. 2023 Oct 23;18(10):e0292667. doi: 10.1371/journal.pone.0292667. eCollection 2023.

    PubMed 37871102

Questions about this trial

What is this clinical trial studying?

An observational study of Capnography and Nasogastric Tube, run by Chinese University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Janita Pak Chun Chau, PhD (+852 3943 6226, janitachau@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensitivity of Capnography (time frame: Through study completion, an average of 2 year). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05817864, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in